Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

M. Nutting, Christopher; P. Morden, James; J. Harrington, Kevin; Guerrero Urbano, Teresa; Bhide, Shreerang; H. Clark, Catharine; Miles, Elizabeth; Miah, Aisha; Newbold, Kate; Anne Tanay, Mary; Adab, F.; Jefferies, Sarah; Scrase, Christopher; Yap, B.; A’Hern, Roger; Sydenham, Mark; A. Emson, Marie; Hall, Emma

doi:10.1016/s1470-2045(10)70290-4

Public

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Published in The Lancet Oncology • Jan 14, 2011

Authors:

Christopher M. Nutting

James P. Morden

Kevin J. Harrington

Abstract

BACKGROUND: Xerostomia is the most common late side-effect of radiotherapy to the head and neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) can reduce irradiation of the parotid glands. We assessed the hypothesis that parotid-sparing IMRT reduces the incidence o...

Subject

Medicine

Head and neck cancer

Radiation therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!